Insiders Were Right: BIIB Makes New 52-Week High


Shutterstock photo

In trading on Tuesday, shares of Biogen Inc (Symbol: BIIB) touched a new 52-week high of $354.28/share. That’s a 45.03% rise, or $110 per share from the 52-week low of $244.28 set back on 05/31/2017. That means at today’s intraday high, any investor who purchased BIIB stock any time over the past 52 weeks has an unrealized gain, including company insiders.

Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, BIIB has seen 2 different instances of insiders buying over the trailing six month period.

Purchased Insider Title Shares Price/Share Value
11/29/2017 Alexander J. Denner Director 30,000 $317.36 $9,520,800.00
12/29/2017 Michel Vounatsos Chief Executive Officer 780 $320.55 $250,029.00
The chart below shows where BIIB has traded over the past year, with the 50-day and 200-day moving averages included. Biogen Inc Moving Averages Chart In afternoon trading on Tuesday, BIIB shares are changing hands at $348.04/share, slightly below the new 52-week high.

Ten Bargains You Can Buy Cheaper Than The Insiders Did »

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


Referenced Symbols: BIIB
No Comments

Post A Comment